| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/01/1996 | WO1996022787A1 Recombinant human alpha-fetoprotein and uses thereof |
| 08/01/1996 | WO1996022776A1 Dermatological use of vitamin d derivatives |
| 08/01/1996 | WO1996022760A2 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
| 08/01/1996 | WO1996016170A3 Proteins involved in the regulation of cell-cell adhesion and uses thereof |
| 08/01/1996 | WO1996013592A3 Protein kinase npk-110 |
| 08/01/1996 | WO1996013259A3 Method and compositions for inhibiting protein kinases |
| 08/01/1996 | WO1995031545A3 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein |
| 08/01/1996 | CA2211443A1 Lymphotoxin-.alpha./.beta. complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 08/01/1996 | CA2210884A1 Dermatological use of vitamin d derivatives |
| 08/01/1996 | CA2210737A1 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
| 08/01/1996 | CA2210724A1 Human interleukin-1 receptor accessory protein |
| 08/01/1996 | CA2208075A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-[1]benzopyran for treating proliferative disorders |
| 07/31/1996 | EP0723956A1 Basically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics as well as medicaments containing them |
| 07/31/1996 | EP0723778A1 Composition for modulation of apoptosis comprising a factor influencing the intracellular level of methional or malondialdehyde |
| 07/31/1996 | EP0723595A1 A novel nuclear mitotic phosphoprotein: mitosin |
| 07/31/1996 | EP0723547A1 Boronated metalloporphyrins and therapeutic methods |
| 07/31/1996 | EP0723540A1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/31/1996 | EP0723539A1 Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/31/1996 | EP0723538A1 Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/31/1996 | EP0723460A1 Gene therapy of the nervous system |
| 07/31/1996 | EP0723457A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 07/31/1996 | EP0723442A1 Lactone compounds for treating patients with precancerous lesions |
| 07/31/1996 | EP0723402A1 Senescent cell-derived inhibitors of dna synthesis |
| 07/31/1996 | EP0648223A4 Substituted lactose derivatives as cell adhesion inhibitors. |
| 07/31/1996 | EP0647219B1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs |
| 07/31/1996 | EP0472661B1 Therapeutic application of an anti-invasion compound |
| 07/31/1996 | EP0469060B1 Autoantibodies which enhance the rate of a chemical reaction |
| 07/31/1996 | CN1128028A N-morpholino-N-nitrosaminoacetonitril cyclodextrin inclusion complexes |
| 07/31/1996 | CN1127757A New tetrahydropyran compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
| 07/31/1996 | CN1127749A Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
| 07/31/1996 | CA2168315A1 Basically-substituted benzoylguanidines, a process for preparing them, their use as a medicament or diagnostic agent, and a medicament containing them |
| 07/30/1996 | US5541343 Cyclic imino derivatives and pharmaceutical compositions containing them |
| 07/30/1996 | US5541339 CC-1065 analogs having two CPI subunits |
| 07/30/1996 | US5541297 Hypoimmunogenic immunoconjugate of antibody fragment which binds to antigen associated with tumor or protozoa conjugated to drug or modified toxin and to polysaccharide or polyether through thiol-binding linker |
| 07/30/1996 | US5541228 Melatonergic agents |
| 07/30/1996 | US5541219 Antiinflammatory agents; aids |
| 07/30/1996 | US5541202 New leukotriene-B4 Antagonists and their use as pharmaceutical agents |
| 07/30/1996 | US5541192 Treating restinosis |
| 07/30/1996 | US5541191 Treating pulmonary inflamation |
| 07/30/1996 | US5541190 Treating benign prostatic hyperplasia, male pattern baldness, prostatic cancer, androgenic alopecia |
| 07/30/1996 | US5541172 Controlled release systems and low dose androgens |
| 07/30/1996 | US5541104 Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1 |
| 07/30/1996 | CA1338489C Pharmaceutical preparation containing 2,6-diamino-3-phenyl-azo-pyridine |
| 07/25/1996 | WO1996022384A1 Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
| 07/25/1996 | WO1996022278A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same |
| 07/25/1996 | WO1996022277A1 Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production |
| 07/25/1996 | WO1996022112A1 Delivery of therapeutic agents by gene therapy |
| 07/25/1996 | WO1996022101A1 Combined therapeutical treatment of hyperproliferative diseases |
| 07/25/1996 | WO1996022085A1 The use of sertraline to treat cancer patients |
| 07/25/1996 | CA2211786A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing same |
| 07/25/1996 | CA2210718A1 Delivery of therapeutic agents by gene therapy |
| 07/25/1996 | CA2210347A1 Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production |
| 07/25/1996 | CA2210158A1 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/24/1996 | EP0723146A1 Up-converting reporters for biological and other assays using laser excitation techniques |
| 07/24/1996 | EP0723016A2 Activating factor of leukocytes |
| 07/24/1996 | EP0723015A1 Novel modified PF4 compositions and methods of use |
| 07/24/1996 | EP0722928A1 Bicyclic-aromatic compounds with strong biologic activity, pharmaceutical and cosmetic compositions containing them and uses thereof |
| 07/24/1996 | EP0722489A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations |
| 07/24/1996 | EP0722446A1 Distamycin a analogues as antitumour or antiviral agents |
| 07/24/1996 | EP0722440A1 Pyrimidinyl-glutamic acid derivatives |
| 07/24/1996 | EP0722438A1 Hydroxamic acid derivatives as inhibitors of cytokine production |
| 07/24/1996 | EP0722431A1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| 07/24/1996 | EP0722343A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 07/24/1996 | EP0722342A1 REGULATION OF bcl-2 GENE EXPRESSION |
| 07/24/1996 | EP0722332A1 Compounds for medicinal use |
| 07/24/1996 | EP0722326A1 Highly sulfated maltooligosaccharides with heparin-like properties |
| 07/24/1996 | EP0722275A1 Cell death regulator |
| 07/24/1996 | EP0581954B1 Use of alpha-hydroxyketoalkyl derivatives as protective light filters |
| 07/24/1996 | CN1127532A Method for diagnosing a disorder by determining expression of GAGE tumor rejection antigen precursors |
| 07/24/1996 | CN1127259A Peptides |
| 07/24/1996 | CN1127117A Application of googerotin used as antineoplastic medicine |
| 07/24/1996 | CN1127115A Use of 5-thia-1,4-diazabicyclo/4.2.0/octane-3,8-dioxo compounds in antitumor therapy |
| 07/23/1996 | US5539103 Compounds for treatment of leukemia or tumors |
| 07/23/1996 | US5539082 Peptide nucleic acids |
| 07/23/1996 | US5538986 Tricyclic derivatives, compositions and methods of use |
| 07/23/1996 | US5538978 9-purinyl phosphonic acid derivatives |
| 07/23/1996 | US5538970 Treatment of cancer with imidazo-1,2-pyridazin compounds |
| 07/23/1996 | US5538949 Angiogenesis inhibitors |
| 07/23/1996 | US5538866 Immunoassay; medical diagnosis |
| 07/23/1996 | US5538725 Method of inhibiting metastasis by anti-α6-integrin-antibodies |
| 07/18/1996 | WO1996021736A1 Human geranylgeranyl pyrophosphate synthetase |
| 07/18/1996 | WO1996021666A1 Camptothecin derivatives and its manufacturing method |
| 07/18/1996 | WO1996021658A1 Hydrophobic taxane derivatives |
| 07/18/1996 | WO1996021656A1 Estrogen agonists/antagonists |
| 07/18/1996 | WO1996021654A1 Novel compounds |
| 07/18/1996 | WO1996021648A1 New piperazine derivatives and methods for the preparation thereof and compositions containing the same |
| 07/18/1996 | WO1996021644A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | WO1996021638A1 Novel compounds |
| 07/18/1996 | WO1996021471A1 Compositions and methods for treating tumor cells |
| 07/18/1996 | WO1996021467A1 BIOTHERAPY OF CANCER BY TARGETING TP-3/p80 |
| 07/18/1996 | WO1996021463A2 New applications of lysozyme dimer |
| 07/18/1996 | WO1996021456A1 Inhibitors of prenyl transferases |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | WO1996021416A2 Methods and compositions for treatment of solid tumors in vivo |
| 07/18/1996 | CA2210322A1 Novel compounds |
| 07/18/1996 | CA2210091A1 New applications of lysozyme dimer |
| 07/18/1996 | CA2209989A1 Compositions and methods for treating tumor cells |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209936A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | CA2209767A1 Biotherapy of cancer by targeting tp-3/p80 |